Business Development USA | Oct 4-9 | Boston & San Diego

The United States is among the world's leading markets in healthcare and medical biotechnology. The sector is characterized by a high rate of innovation, strong investments in research and development, and a well-developed life sciences infrastructure. Medical biotechnology, in particular, is considered a key growth driver, especially in areas such as personalized medicine, cell and gene therapies, mRNA technologies, and biopharmaceutical applications.

This presents attractive market opportunities for German companies in the healthcare and medical biotechnology sectors. Specialized, research-oriented solutions with high clinical relevance are particularly in demand. German companies can leverage their scientific excellence, regulatory expertise, and high standards in data protection and quality assurance as competitive advantages in the US market.